ACE2 and COVID-19: ACE2, the COVID-19 receptor, was included in COVID-19 cocktails since plasma sACE2 levels are significantly higher in COVID-19 patients in intensive care (34, 35) and in elderly and metabolic syndrome patients who are predisposed to severe COVID-19 disease (36).